Reducing PTSD symptoms for first responders and frontline health workers
Part of Mental health clinical trials.
This study tests a way to help reduce PTSD symptoms in first responders and frontline healthcare workers. You may join a main treatment study, and some participants may also take part in follow-up questions to learn what helped.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You work for an organization that is served by a participating employee assistance program (EAP)
- You have PTSD symptoms on the PCL-5 screening, with a score of 33 or higher
- Your psychiatric medicine has been stable for at least 4 weeks (no major changes)
- You must not already be in a trauma-focused therapy like Prolonged Exposure or Cognitive Processing Therapy
- You can participate safely: not have severe memory/thinking problems, and not be at high suicide risk
- You must speak English
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how a therapy called “prolonged exposure” works for people with post-traumatic stress disorder (PTSD). You may be able to join if you have PTSD, are interested in starting prolonged exposure, and meet other safety and participation rules.
This trial tests if early support from a municipal crisis team can help people who have been through a traumatic event. It may be a good option if you have symptoms of post-traumatic stress and want to see if extra support soon after the event can help you feel better.
This study tests whether a medication called MDMA, when combined with therapy sessions, can help reduce stress and trauma symptoms in healthcare workers and first responders. The goal is to see if this treatment improves their well-being and ability to cope with job-related stress.
This study looks at psychological distress, including post-traumatic stress disorder (PTSD), in healthcare workers after work-related trauma. You may be eligible if you are an adult healthcare worker with PTSD (and otherwise stable) who can complete regular study check-ins.
This study tests a short, focused therapy (SEE FAR CBT) for adults with PTSD. It's a type of talk therapy that helps you process trauma, and the study wants to see if it works better than the usual care you would get.
This study tests a new oral medication called PT150 to see if it helps reduce PTSD symptoms in Veterans. Participation involves taking the medication, regular check-ups, and questionnaires.
Hear when a new PTSD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.